OTLK · Outlook Therapeutics, Inc.
$0.98
-0.05 (-5.02%)
At close · Aug 6
Going-concern doubt
— flagged May 15, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, there is substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed May 15, 2026
Market Cap
$117.54M
Shares
120.86M
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-05-07 | New | Biotechnology | $5,000,000 | $0 | 06b |
| 2025-01-27 | New | Biotechnology | $31,977,359 | $0 | 06b |
| 2024-04-16 | New | Biotechnology | $13,250,005 | $5,000,002 | 06b |
| 2024-03-29 | New | Biotechnology | $159,000,000 | $60,000,000 | 06b |
| 2023-01-06 | New | Biotechnology | $1,031,510 | $1,031,510 | 06b |
| 2023-01-06 | New | Biotechnology | $31,820,000 | $31,820,000 | 06b |
| 2021-02-12 | New | Biotechnology | $4,013,627 | $4,013,627 | 06b |
| 2020-06-09 | New | Biotechnology | $16,000,000 | $16,000,000 | 06b |
| 2020-03-11 | New | Other | $7,971,155 | $7,971,155 | 06b |
Showing 1–9 of 9 filings
Key facts
CIK
1649989
CUSIP
69012T305
13F (30d)
16 filings
16 filers
Visit website
Investor relations